Closing the gaps in TB detection — considerations for policy makers

Decentralised molecular testing for TB could reduce missed diagnoses and losses to follow-up in high-burden settings.

A study published in The Lancet Global Health reported on the cost and cost-effectiveness analysis of decentralised molecular testing for TB in Uganda.

An accompanying comment can be accessed here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:

By Ryan R Thompson, MSPH et al.

Published: Jan. 22, 2023, 8:27 p.m.

Last updated: Jan. 22, 2023, 11:30 p.m.

Tags: Diagnostics

Print Share